Search
Now showing items 21-30 of 46
Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria (Review)
(Cochrane Collaboration, 2010)
Background
Multiple-drug-resistant malaria is widespread, and in South-East Asia resistance is high against nearly all single therapy antimalarial drugs. Here, and in other areas with low malaria transmission, the combination ...
Genetic polymorphisms in plasmodium falciparum associated with resistance to artemisnin combination therapy: complexity of infection during short-term culture and characterization of in-vitro sensitivity in Kampala Uganda
(2010)
Background Artemisinin-based combination therapy (ACT) is currently advocated in Africa as a means of improving treatment efficacy and slowing the development of drug resistance. However, the selection of resistant parasites, ...
An assessment of Makerere University College of Health Sciences: optimizing health research capacity to meet Uganda’s priorities
(BioMed Central, 2011)
Background: Health research is critical to the institutional mission of the Makerere College of Health Sciences (MakCHS). Optimizing the alignment of health research capacity at MakCHS with the health needs and priorities ...
Prevalence and factors associated with malaria in children receiving systemic cancer chemotherapy at Uganda Cancer Institute
(Makerere University, 2018)
Background: Although significant strides have been made towards prevention, malaria remains
endemic in parts of Uganda and is still one of the top 5 causes of mortality among children aged
under 5 years. The detection ...
A cost effectiveness analysis of quinine or artemisinins in management of severe malaria in pregnancies at Mulago Hospital.
(Makerere University, 2014)
Introduction: Malaria kills one million people each year in the world. It accounts for up to 40% of all outpatient attendances, 20% of all admissions and 14% of all in-patient deaths in Uganda. Among pregnant women, it ...
Plasma levels of DDT/DDE and liver function in malaria control personnel prior to DDT in-door residual spray in Northern Uganda, 2008
(African Journal of Animal and Biomedical Sciences, 2010)
Where 20 million Ugandans are debilitated by malaria in a year, there is continued need of
dichlorodiphenyltrichloroethane (DDT) for vector control while further research is implemented to clarify the
health impact of ...
Quality of care for children under five years with uncomplicated malaria at private clinics in Makindye Division, Kampala District
(Makerere University, 2015-11)
Introduction: Over 60% of the population in developing countries seeks for care from private health facilities. In Uganda over 80% of the population access health care from small drug shops, private clinics and private-not-for ...
Effect of repeated anthelminthic treatment on malaria in school children in Kenya: A randomized, open label, equivalence trial
(Makerere University, 2016)
Background: In Africa, malaria and soil-transmitted helminths (STHs) occur in the same populations and sometimes in the same individuals, with school-age children being at the greatest risk of coinfection. It has been ...
Prevalence, severity and clinical characteristics of acute kidney injury among children with severe malaria at Mulago Hospital.
(Makerere University, 2014)
Background: There were 219 million malaria cases reported in 2010, and 660,000 deaths of which 91% were in Sub Saharan Africa. Disordered renal physiology in patients with severe malaria is associated with 45% mortality. ...
Evaluation of availability and use of chroloqiune plus sulfadoxine pyrimethamine in Lira District
(Makerere University, 2013-01)
Background
Half of the world’s population is at the risk of malaria and an estimated 243million cases led to nearly 830,000 deaths in 2008, with most of the cases and death found in Africa. The morbidity and mortality ...